Molecular Partners AG
Status: Publicly traded
Direct answer
Molecular Partners AG is publicly traded on NASDAQ under the ticker MOLN.
Molecular Partners AG operates as a clinical-stage biopharmaceutical company, specializing in the identification, advancement, and commercialization of innovative therapeutic proteins. The firm's pipeline includes a range of product candidates, many of which utilize its proprietary DARPin® technology. Key developments include Abicipar, a DARPin therapeutic in Phase III clinical trials for addressing neovascular wet...
Can you invest in Molecular Partners AG?
Yes. Molecular Partners AG trades publicly on NASDAQ as MOLN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Molecular Partners AG
Detailed equity research is provided by MarketSnap.